Registered Nurse in Maite, GU Accepting Medicare
4 Registered Nurse nurses found. Showing 1 - 4
 Mr. Rosalo Desamito Paeste Iii, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Route 8 Ste 303, Maite, GU 96910 Phone: 671-475-0061 |
 Christine Joyce Gloria Cristobal, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Route 8 Ste 303, Maite, GU 96910 Phone: 671-475-0061 Fax: 671-475-0065 |
Mrs. Claire Bayona Ganon, RN, GERO-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Route 8, Maite, GU 96910 Phone: 671-475-0061 |
Joan Unsay, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Route 8 Ste 303, Maite, GU 96910 Phone: 671-475-0061 |
News Archive
FDA approves SPA Protocol Amendment for Lucanix Phase III clinical trial
NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol Amendment to the pivotal Lucanix® Phase III clinical trial in patients with Non-Small Cell Lung Cancer (NSCLC).
Data from Purdue Pharma's Butrans clinical trials to be presented at APS annual meeting
Purdue Pharma L.P. will present an analysis of data from completed clinical trials for Butrans® (buprenorphine) Transdermal System CIII at the American Pain Society's (APS) 31st Annual Scientific Meeting.
Prevention of preterm birth and stillbirth: Global collaborative efforts needed
A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.
ORC Guideline's recent research on the impact of social media and pharmaceutical marketing
Chief Research Officer Morris S. Whitcup, Ph.D., of ORC Guideline (an infoGROUP company) (NASDAQ: IUSA) will present findings of the company's recent research on the impact of social media on fair balance and pharmaceutical marketing at a Food and Drug Administration (FDA) public hearing later this week. The hearing will address the issue of fulfilling requirements for fair balance and risk disclosure in internet and social media promotions. The ORC Guideline study examined consumer habits in researching information about pharmaceutical products online.
› Verified 6 days ago